These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 18474814)

  • 1. Novel role for inhibitor of differentiation 2 in the genesis of angiotensin II-induced hypertension.
    Gratze P; Dechend R; Stocker C; Park JK; Feldt S; Shagdarsuren E; Wellner M; Gueler F; Rong S; Gross V; Obst M; Plehm R; Alenina N; Zenclussen A; Titze J; Small K; Yokota Y; Zenke M; Luft FC; Muller DN
    Circulation; 2008 May; 117(20):2645-56. PubMed ID: 18474814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting the calpain/calpastatin system as a new strategy to prevent cardiovascular remodeling in angiotensin II-induced hypertension.
    Letavernier E; Perez J; Bellocq A; Mesnard L; de Castro Keller A; Haymann JP; Baud L
    Circ Res; 2008 Mar; 102(6):720-8. PubMed ID: 18258859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Essential role of angiotensin II type 1a receptors in the host vascular wall, but not the bone marrow, in the pathogenesis of angiotensin II-induced atherosclerosis.
    Koga J; Egashira K; Matoba T; Kubo M; Ihara Y; Iwai M; Horiuchi M; Sunagawa K
    Hypertens Res; 2008 Sep; 31(9):1791-800. PubMed ID: 18971558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nox1 is involved in angiotensin II-mediated hypertension: a study in Nox1-deficient mice.
    Matsuno K; Yamada H; Iwata K; Jin D; Katsuyama M; Matsuki M; Takai S; Yamanishi K; Miyazaki M; Matsubara H; Yabe-Nishimura C
    Circulation; 2005 Oct; 112(17):2677-85. PubMed ID: 16246966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerebral vascular effects of angiotensin II: new insights from genetic models.
    Faraci FM; Lamping KG; Modrick ML; Ryan MJ; Sigmund CD; Didion SP
    J Cereb Blood Flow Metab; 2006 Apr; 26(4):449-55. PubMed ID: 16094317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aldosterone synthase inhibitor ameliorates angiotensin II-induced organ damage.
    Fiebeler A; Nussberger J; Shagdarsuren E; Rong S; Hilfenhaus G; Al-Saadi N; Dechend R; Wellner M; Meiners S; Maser-Gluth C; Jeng AY; Webb RL; Luft FC; Muller DN
    Circulation; 2005 Jun; 111(23):3087-94. PubMed ID: 15939810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complement activation in angiotensin II-induced organ damage.
    Shagdarsuren E; Wellner M; Braesen JH; Park JK; Fiebeler A; Henke N; Dechend R; Gratze P; Luft FC; Muller DN
    Circ Res; 2005 Sep; 97(7):716-24. PubMed ID: 16109917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel gene (Cmya3) induced in the heart by angiotensin II-dependent but not salt-dependent hypertension in mice.
    Duka A; Schwartz F; Duka I; Johns C; Melista E; Gavras I; Gavras H
    Am J Hypertens; 2006 Mar; 19(3):275-81. PubMed ID: 16500513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rosuvastatin protects against angiotensin II-induced renal injury in a dose-dependent fashion.
    Park JK; Mervaala EM; Muller DN; Menne J; Fiebeler A; Luft FC; Haller H
    J Hypertens; 2009 Mar; 27(3):599-605. PubMed ID: 19262227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin II induces premature senescence of vascular smooth muscle cells and accelerates the development of atherosclerosis via a p21-dependent pathway.
    Kunieda T; Minamino T; Nishi J; Tateno K; Oyama T; Katsuno T; Miyauchi H; Orimo M; Okada S; Takamura M; Nagai T; Kaneko S; Komuro I
    Circulation; 2006 Aug; 114(9):953-60. PubMed ID: 16908765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Id2 is dispensable for myc-induced lymphomagenesis.
    Nilsson JA; Nilsson LM; Keller U; Yokota Y; Boyd K; Cleveland JL
    Cancer Res; 2004 Oct; 64(20):7296-301. PubMed ID: 15492249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nox1 overexpression potentiates angiotensin II-induced hypertension and vascular smooth muscle hypertrophy in transgenic mice.
    Dikalova A; Clempus R; Lassègue B; Cheng G; McCoy J; Dikalov S; San Martin A; Lyle A; Weber DS; Weiss D; Taylor WR; Schmidt HH; Owens GK; Lambeth JD; Griendling KK
    Circulation; 2005 Oct; 112(17):2668-76. PubMed ID: 16230485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calsarcin-1 protects against angiotensin-II induced cardiac hypertrophy.
    Frank D; Kuhn C; van Eickels M; Gehring D; Hanselmann C; Lippl S; Will R; Katus HA; Frey N
    Circulation; 2007 Nov; 116(22):2587-96. PubMed ID: 18025526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dual role for Id2 in chemical carcinogen-induced skin tumorigenesis.
    Tokuriki A; Iyoda T; Inaba K; Ikuta K; Fujimoto S; Kumakiri M; Yokota Y
    Carcinogenesis; 2009 Sep; 30(9):1645-50. PubMed ID: 19587095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL6 suppression provides renal protection independent of blood pressure in a murine model of salt-sensitive hypertension.
    Manhiani MM; Quigley JE; Socha MJ; Motamed K; Imig JD
    Kidney Blood Press Res; 2007; 30(4):195-202. PubMed ID: 17575466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Innate and acquired immunity in angiotensin-induced malignant hypertension].
    Luft FC
    Verh Dtsch Ges Pathol; 2002; 86():76-82. PubMed ID: 12647354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiotensin II increases intrarenal transforming growth factor-beta1 in rats submitted to sodium overload independently of blood pressure.
    Rosón MI; Cao G; Della Penna S; Gorzalczany S; Pandolfo M; Toblli JE; Fernández BE
    Hypertens Res; 2008 Apr; 31(4):707-15. PubMed ID: 18633183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CCR5 deficiency does not reduce hypertensive end-organ damage in mice.
    Krebs C; Fraune C; Schmidt-Haupt R; Turner JE; Panzer U; Quang MN; Tannapfel A; Velden J; Stahl RA; Wenzel UO
    Am J Hypertens; 2012 Apr; 25(4):479-86. PubMed ID: 22258337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulatory T cells ameliorate angiotensin II-induced cardiac damage.
    Kvakan H; Kleinewietfeld M; Qadri F; Park JK; Fischer R; Schwarz I; Rahn HP; Plehm R; Wellner M; Elitok S; Gratze P; Dechend R; Luft FC; Muller DN
    Circulation; 2009 Jun; 119(22):2904-12. PubMed ID: 19470887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of myosin light chain kinase expression by angiotensin II in hypertension.
    Han YJ; Hu WY; Piano M; de Lanerolle P
    Am J Hypertens; 2008 Aug; 21(8):860-5. PubMed ID: 18511912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.